机译:边缘区淋巴瘤患者的临床特征及可能的预后因素:两个中心的回顾性分析
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
Gulhane Training &
Res Hosp Dept Hematol Ankara Turkey;
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
Gulhane Training &
Res Hosp Dept Hematol Ankara Turkey;
Diskapi Yildirim Beyazit Training &
Res Hosp Dept Hematol Ankara Turkey;
机译:边缘区淋巴瘤患者的临床特征及可能的预后因素:两个中心的回顾性分析
机译:与滤泡性淋巴瘤相比,淋巴结边缘区淋巴瘤患者的临床特征:相似的表现,但预后因素和转化率存在差异
机译:脊柱脊索瘤患者的临床特征和预后因素:单中心153例患者的回顾性分析
机译:CD180:血浆膜微粒蛋白质组学分析发现的新边缘区B细胞淋巴瘤生物标志物
机译:弥漫性大B细胞淋巴瘤化疗后患者生存的预后生物标志物:88例回顾性分析
机译:脊柱脊索瘤患者的临床特征和预后因素:单中心153例患者的回顾性分析
机译:脊柱脊髓瘤患者的临床特征及预后因素:对单一中心153例患者的回顾性分析